Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision Next revision | Previous revision | ||
|
publications [2026/03/10 16:01] ramirez [2026] |
publications [2026/05/25 16:51] (current) ramirez [2025] |
||
|---|---|---|---|
| Line 2: | Line 2: | ||
| ===== 2026 ===== | ===== 2026 ===== | ||
| - | Tsiodras S, Gupta N, Hanscheid T, Jokelainen P, Drexler JF, Barac A, Gkrania-Klotsas E, Mora-Rillo M, Bulescu C, Paño-Pardo JR, Lescure FX, Grobusch MP. 2026. <fc #0000FF>Language, trust, and the polio endgame: words matter in vaccine communication</fc>. Clin Microbiol Infect S1198-743X(26)00081–9. | + | van Os J, de Jong HK, Pellejero-Sagastizabal G, Paño-Pardo JR, Lescure F-X, Hanscheid T, Grobusch MP, Goorhuis A. 2026. <fc #0000FF>Analysing outbreak signals, 2013-2024: the Amsterdam UMC centre for tropical medicine and travel medicine epi alert programme - an observational study</fc>. New Microbes New Infect 71:101756. [[https://www.ncbi.nlm.nih.gov/pubmed/42125210/|(PMID: 42125210)]]. |
| - | Martins ER, Forofontov M, Mota Freitas J, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]]. 2026. <fc #0000FF>Two //Streptococcus agalactiae// ST283 invasive infections in Portugal raise the possibility of the emergence of this unusual lineage in Europe</fc>. Front Microbiol 16: 1712362. | + | Grobusch MP, Adegbite BR, Hanscheid T, Gupta N. 2026. <fc #0000FF>The impact of state-of-the-art pharmacotherapy for malaria in infants: a breakthrough?</fc> Expert Opin Pharmacother 1–3 [[https://www.ncbi.nlm.nih.gov/pubmed/42059410/|(PMID: 42059410)]]. |
| + | |||
| + | Grobusch MP, Schnyder JL, Schlagenhauf P, de Jong HK, Hanscheid T. 2026. <fc #0000FF>Malaria prevention: progress to date</fc>. Drugs //In press// [[https://www.ncbi.nlm.nih.gov/pubmed/42045630/|(PMID: 42045630)]]. | ||
| + | |||
| + | Mamede R, Vila-Cerqueira P, Carriço JA, [[people:ramirez|Ramirez M]]. 2026. <fc #0000FF>chewBBACA 3: lowering the barrier for scalable and detailed whole- and core-genome multilocus sequence typing</fc>. Genome Med 18:51. [[https://www.ncbi.nlm.nih.gov/pubmed/41877275/|(PMID: 41877275)]]. | ||
| + | |||
| + | de Oliveira LOV, Ferreira LMSR, de Pereira DSCA, Firmino FT, Candal MS, Pereira HS, de Carli Farias da Silva G, Morellato SA, Geiger SM, Negrão-Corrêa D, Dollabella S, Fujiwara RT, Hanscheid T, Graeff-Teixeira C. 2026. <fc #0000FF>Modifications of the helmintex method: integration of treatments with tween 20, cellulase, percoll and auramine-O staining for detection of //Schistosoma mansoni// eggs</fc>. Trop med int health //In press// [[https://www.ncbi.nlm.nih.gov/pubmed/41830103/|(PMID: 41830103)]]. | ||
| + | |||
| + | Pereira DSC de A, Oliveira LOVO, Firmino FT, Hanscheid T, Pulak R, Jones M, Dolabella S, Negrão-Corrêa D, Graeff-Teixeira C. 2026. <fc #0000FF>Miracidia as main source for autofluorescence of //Schistosoma mansoni// eggs</fc>. Mem Inst Oswaldo Cruz 121:e250215. [[https://www.ncbi.nlm.nih.gov/pubmed/41810683/|(PMID: 41810683)]]. | ||
| + | |||
| + | van der Ende J, Davila MV, Coloma J, Schallig H, Hanscheid T, Grobusch MP. 2026. <fc #0000FF>Presence of dengue virus NS1 antigen and IgM and IgG antibodies in asymptomatic individuals in ecuadorian amazonia - a descriptive repeated cross-sectional community-based survey</fc>. New Microbes New Infect 70:101728. [[https://www.ncbi.nlm.nih.gov/pubmed/41783243/|(PMID: 41783243)]]. | ||
| + | |||
| + | Tsiodras S, Gupta N, Hanscheid T, Jokelainen P, Drexler JF, Barac A, Gkrania-Klotsas E, Mora-Rillo M, Bulescu C, Paño-Pardo JR, Lescure FX, Grobusch MP. 2026. <fc #0000FF>Language, trust, and the polio endgame: words matter in vaccine communication</fc>. Clin Microbiol Infect S1198-743X(26)00081–9. [[https://www.ncbi.nlm.nih.gov/pubmed/41765092/|(PMID: 41765092)]]. | ||
| + | |||
| + | Martins ER, Forofontov M, Mota Freitas J, [[people:jmelocristino|Melo-Cristino J]], [[people:ramirez|Ramirez M]]. 2026. <fc #0000FF>Two //Streptococcus agalactiae// ST283 invasive infections in Portugal raise the possibility of the emergence of this unusual lineage in Europe</fc>. Front Microbiol 16: 1712362. [[https://www.ncbi.nlm.nih.gov/pubmed/41669694/|(PMID: 41669694)]]. | ||
| + | |||
| + | Boto CM, Raposo Carneiro S, Ramalho M, Passos Coelho I, Moitinho de Almeida I, Ferreira C, Tomé ML, Sousa Dias M, Araújo Carvalho A, Machado R, Oliveira M, Seruca M, Boto L, Prata F, Penteado R, Carmo A, Rodrigues F, Tavares M, Rebelo S, Ribeiro M, [[people:jfsilva|Gomes-Silva J]], [[people:afriaes|Friães A]], [[people:anacosta|Silva-Costa C]], [[people:ramirez|Ramirez M]], [[people:jmelocristino|Melo-Cristino J]], Pereira Lemos A, Gouveia C. 2025. <fc #0000FF>Increasingly frequent parapneumonic empyema by group A streptococcus is more severe than by //Streptococcus pneumoniae//</fc>. Pediatr Infect Dis J 45:312–316 [[https://www.ncbi.nlm.nih.gov/pubmed/41334964/|(PMID: 41334964)]]. | ||
| ===== 2025 ===== | ===== 2025 ===== | ||
| Line 11: | Line 27: | ||
| Mahomed SM, Hanscheid T, Almeida Y, Grobusch MP, Rebelo M. 2025. <fc #0000FF>Improving reproducibility of //Plasmodium falciparum// culture: a large-language-model-driven literature review and a parasite growth variability assessment of donor red blood cells</fc>. Malar J 25:46 [[https://www.ncbi.nlm.nih.gov/pubmed/41398683/|(PMID: 41398683)]]. | Mahomed SM, Hanscheid T, Almeida Y, Grobusch MP, Rebelo M. 2025. <fc #0000FF>Improving reproducibility of //Plasmodium falciparum// culture: a large-language-model-driven literature review and a parasite growth variability assessment of donor red blood cells</fc>. Malar J 25:46 [[https://www.ncbi.nlm.nih.gov/pubmed/41398683/|(PMID: 41398683)]]. | ||
| - | Boto CM, Raposo Carneiro S, Ramalho M, Passos Coelho I, Moitinho de Almeida I, Ferreira C, Tomé ML, Sousa Dias M, Araújo Carvalho A, Machado R, Oliveira M, Seruca M, Boto L, Prata F, Penteado R, Carmo A, Rodrigues F, Tavares M, Rebelo S, Ribeiro M, [[people:jfsilva|Gomes-Silva J]], [[people:afriaes|Friães A]], [[people:anacosta|Silva-Costa C]], [[people:ramirez|Ramirez M]], [[people:jmelocristino|Melo-Cristino J]], Pereira Lemos A, Gouveia C. 2025. <fc #0000FF>Increasingly frequent parapneumonic empyema by group A streptococcus is more severe than by //Streptococcus pneumoniae//</fc>. Pediatr Infect Dis J //In press// [[https://www.ncbi.nlm.nih.gov/pubmed/41334964/|(PMID: 41334964)]]. | + | van der Ende J, Bezemer JM, Hanscheid T, Grobusch MP, Trueba G. 2025. <fc #0000FF>Amazon environment sharing featuring humans - dogs - capybaras and more. Adapting a one-health approach to leptospirosis prevention in indigenous riverine communities in Ecuador and beyond</fc>. New Microbes New Infect 68:101658 [[https://www.ncbi.nlm.nih.gov/pubmed/41278579/|(PMID: 41278579)]]. |
| - | + | ||
| - | van der Ende J, Bezemer JM, Hanscheid T, Grobusch MP, Trueba G. 2025. Amazon environment sharing featuring humans - dogs - capybaras and more. Adapting a one-health approach to leptospirosis prevention in indigenous riverine communities in Ecuador and beyond. New Microbes New Infect 68:101658 [[https://www.ncbi.nlm.nih.gov/pubmed/41278579/|(PMID: 41278579)]]. | + | |
| Guerreiro-Nunes A, [[people:anacosta|Silva-Costa C]], [[people:jfsilva|Gomes-Silva J]], [[people:ramirez|Ramirez M]], [[people:jmelocristino|Melo-Cristino J]], Portuguese Group for the Study of Streptococcal Infections. 2025. <fc #0000FF>The resilience of vaccine serotypes in adult invasive pneumococcal disease in Portugal, 2018-2023</fc>. Sci Rep 15:40146. [[https://www.ncbi.nlm.nih.gov/pubmed/41249230/|(PMID: 41249230)]]. | Guerreiro-Nunes A, [[people:anacosta|Silva-Costa C]], [[people:jfsilva|Gomes-Silva J]], [[people:ramirez|Ramirez M]], [[people:jmelocristino|Melo-Cristino J]], Portuguese Group for the Study of Streptococcal Infections. 2025. <fc #0000FF>The resilience of vaccine serotypes in adult invasive pneumococcal disease in Portugal, 2018-2023</fc>. Sci Rep 15:40146. [[https://www.ncbi.nlm.nih.gov/pubmed/41249230/|(PMID: 41249230)]]. | ||
| Line 37: | Line 51: | ||
| Stanley S, [[people:anacosta|Silva-Costa C]], [[people:jfsilva|Gomes-Silva J]], [[people:jmelocristino|Melo-Cristino J]], Malley R, [[people:ramirez|Ramirez M]]. 2025. <fc #0000FF>CC180 clade dynamics do not universally explain //Streptococcus pneumoniae// serotype 3 persistence post-vaccine: a global comparative population genomics study</fc>. Ebiomedicine 117:105781. [[https://www.ncbi.nlm.nih.gov/pubmed/40472804/|(PMID: 40472804)]] | Stanley S, [[people:anacosta|Silva-Costa C]], [[people:jfsilva|Gomes-Silva J]], [[people:jmelocristino|Melo-Cristino J]], Malley R, [[people:ramirez|Ramirez M]]. 2025. <fc #0000FF>CC180 clade dynamics do not universally explain //Streptococcus pneumoniae// serotype 3 persistence post-vaccine: a global comparative population genomics study</fc>. Ebiomedicine 117:105781. [[https://www.ncbi.nlm.nih.gov/pubmed/40472804/|(PMID: 40472804)]] | ||
| - | Carvalho BT, Meirinhos SV, Domingos GJ, Peixoto S, [[people:jmelocristino|Melo-Cristino J]]. 2025. <fc #0000FF>Unseen but unforgettable - refractive bacilli in the Gram stain of a muscular abscess</fc>. Eur J Clin Microbiol Infect Dis //In press// [[https://www.ncbi.nlm.nih.gov/pubmed/40307630/|(PMID: 40307630)]] | + | Carvalho BT, Meirinhos SV, Domingos GJ, Peixoto S, [[people:jmelocristino|Melo-Cristino J]]. 2025. <fc #0000FF>Unseen but unforgettable - refractive bacilli in the Gram stain of a muscular abscess</fc>. Eur J Clin Microbiol Infect Dis 44:1749-1752 [[https://www.ncbi.nlm.nih.gov/pubmed/40307630/|(PMID: 40307630)]] |
| Schnyder JL, de Jong HK, Bache EB, van Hest RM, Bélard S, Hanscheid T, Kremsner PG, Grobusch MP. 2025. <fc #0000FF>Which trial do we need? A randomised controlled study to compare the protective efficacy of early post-exposure discontinuation versus standard atovaquone-proguanil malaria prophylaxis in a human //Plasmodium falciparum// challenge model</fc>. Clin Microbiol Infect 31:1618–1622. [[https://www.ncbi.nlm.nih.gov/pubmed/40294866/|(PMID: 40294866)]] | Schnyder JL, de Jong HK, Bache EB, van Hest RM, Bélard S, Hanscheid T, Kremsner PG, Grobusch MP. 2025. <fc #0000FF>Which trial do we need? A randomised controlled study to compare the protective efficacy of early post-exposure discontinuation versus standard atovaquone-proguanil malaria prophylaxis in a human //Plasmodium falciparum// challenge model</fc>. Clin Microbiol Infect 31:1618–1622. [[https://www.ncbi.nlm.nih.gov/pubmed/40294866/|(PMID: 40294866)]] | ||